Squamous Cell Carcinoma of the Urinary Tract

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-10-03
Clinical Trial Update: Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC). [Phase 2]
Phase 2 clinical trial update for atezolizumab in immunotherapy-naive patients with urinary tract squamous cell carcinoma (UTSCC).